Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7A56

Schmallenberg Virus Envelope Glycoprotein Gc Fusion Domains in Postfusion Conformation

Summary for 7A56
Entry DOI10.2210/pdb7a56/pdb
DescriptorEnvelopment polyprotein, CHLORIDE ION, PHOSPHATE ION, ... (6 entities in total)
Functional Keywordsvirus entry, class ii membrane fusion protein, viral protein
Biological sourceBovine Schmallenberg virus BH80/Germany/2011
Total number of polymer chains1
Total formula weight48928.67
Authors
Hellert, J.,Guardado-Calvo, P.,Rey, F.A. (deposition date: 2020-08-20, release date: 2021-09-01, Last modification date: 2024-10-16)
Primary citationHellert, J.,Aebischer, A.,Haouz, A.,Guardado-Calvo, P.,Reiche, S.,Beer, M.,Rey, F.A.
Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein.
Cell Rep, 42:112142-112142, 2023
Cited by
PubMed Abstract: La Crosse virus, responsible for pediatric encephalitis in the United States, and Schmallenberg virus, a highly teratogenic veterinary virus in Europe, belong to the large Orthobunyavirus genus of zoonotic arthropod-borne pathogens distributed worldwide. Viruses in this under-studied genus cause CNS infections or fever with debilitating arthralgia/myalgia syndromes, with no effective treatment. The main surface antigen, glycoprotein Gc (∼1,000 residues), has a variable N-terminal half (Gc) targeted by the patients' antibody response and a conserved C-terminal moiety (Gc) responsible for membrane fusion during cell entry. Here, we report the X-ray structure of post-fusion La Crosse and Schmallenberg virus Gc, revealing the molecular determinants for hairpin formation and trimerization required to drive membrane fusion. We further experimentally confirm the role of residues in the fusion loops and in a vestigial endoplasmic reticulum (ER) translocation sequence at the Gc-Gc junction. The resulting knowledge provides essential molecular underpinnings for future development of potential therapeutic treatments and vaccines.
PubMed: 36827185
DOI: 10.1016/j.celrep.2023.112142
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.85 Å)
Structure validation

235183

PDB entries from 2025-04-23

PDB statisticsPDBj update infoContact PDBjnumon